H1 2026 Earnings
Financial report interval: 2025.12.30 - 2026.06.30
Overview: WuXi Biologics(WXXWY) the Revenue is 1.735 B (+25.02%), Beat estimate;the EBIT is 564.48 M (+41.65%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
1.74B25.02%
1.69B21.69%
+0.05B3.33%
EBITExceed expectations
0.56B41.65%
0.48B19.33%
+0.09B22.32%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf